ClinVar Genomic variation as it relates to human health
NM_000041.3(APOE):c.[388T>C;805C>G]
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
NM_000041.3(APOE):c.[388T>C;805C>G]
- Other names
- APOE, CYS112ARG AND ARG251GLY
- Functional consequence
- -
- Links
- ClinGen: CA041740
- OMIM: 107741.0022
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
APOE | - | - |
GRCh38 GRCh37 |
175 | 195 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
no assertion criteria provided
|
May 1, 1993 | RCV000019455.41 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 01, 1993)
|
no assertion criteria provided
Method: literature only
|
HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE3
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000039745.5
First in ClinVar: Apr 04, 2013 Last updated: Nov 24, 2019 |
Comment on evidence:
Van den Maagdenberg et al. (1993) identified in Dutch subjects with hypertriglyceridemia (617347) 2 substitutions in an APOE3 allele: cys112arg and arg251gly. The authors designated … (more)
Van den Maagdenberg et al. (1993) identified in Dutch subjects with hypertriglyceridemia (617347) 2 substitutions in an APOE3 allele: cys112arg and arg251gly. The authors designated the allele APOE3(Cys112-Arg; Arg251-Gly). (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. | Le Guen Y | JAMA neurology | 2022 | PMID: 35639372 |
APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia. | Abou Khalil Y | International journal of molecular sciences | 2022 | PMID: 35628605 |
Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer's disease and frontotemporal dementia. | Pagnon de la Vega M | BMC genomics | 2022 | PMID: 35120450 |
APOE and dementia - resequencing and genotyping in 105,597 individuals. | Rasmussen KL | Alzheimer's & dementia : the journal of the Alzheimer's Association | 2020 | PMID: 32808727 |
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. | Montagne A | Nature | 2020 | PMID: 32376954 |
Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease. | Ruskey JA | European journal of medical genetics | 2019 | PMID: 29842932 |
Differential burden of rare protein truncating variants in Alzheimer's disease patients compared to centenarians. | Freudenberg-Hua Y | Human molecular genetics | 2016 | PMID: 27260402 |
Rare and common variants in the Apolipoprotein E gene in healthy oldest old. | Tindale LC | Neurobiology of aging | 2014 | PMID: 24126160 |
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. | Reitz C | JAMA | 2013 | PMID: 23571587 |
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. | Liu CC | Nature reviews. Neurology | 2013 | PMID: 23296339 |
Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation. | Marduel M | Human mutation | 2013 | PMID: 22949395 |
APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. | Youmans KL | The Journal of biological chemistry | 2012 | PMID: 23060451 |
Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis. | Yin YW | Neuroscience letters | 2012 | PMID: 22381401 |
Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations. | Choi JH | Molecular genetics and metabolism | 2011 | PMID: 21742527 |
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. | Sidransky E | The New England journal of medicine | 2009 | PMID: 19846850 |
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. | Caselli RJ | The New England journal of medicine | 2009 | PMID: 19605830 |
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. | Nichols WC | Neurology | 2009 | PMID: 18987351 |
Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry. | Fairley C | Journal of inherited metabolic disease | 2008 | PMID: 18979180 |
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). | Hruska KS | Human mutation | 2008 | PMID: 18338393 |
APOE genotype and cognitive decline in a middle-aged cohort. | Blair CK | Neurology | 2005 | PMID: 15668424 |
Impact of APOE in mild cognitive impairment. | Farlow MR | Neurology | 2004 | PMID: 15557508 |
APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury. | Koponen S | Neurology | 2004 | PMID: 15326261 |
Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. | Caselli RJ | Neurology | 2004 | PMID: 15184602 |
Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms. | Montfort M | Human mutation | 2004 | PMID: 15146461 |
Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. | Enzinger C | Annals of neurology | 2004 | PMID: 15048896 |
ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. | DeMattos RB | Neuron | 2004 | PMID: 14741101 |
APOE genotype influences acquisition and recall following traumatic brain injury. | Crawford FC | Neurology | 2002 | PMID: 11940706 |
Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury. | Liberman JN | Neurology | 2002 | PMID: 11940689 |
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. | Mori E | Annals of neurology | 2002 | PMID: 11835377 |
Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. | Buttini M | Neuroscience | 2000 | PMID: 10799751 |
Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. | Friedman G | Neurology | 1999 | PMID: 9932938 |
Association of apolipoprotein E polymorphism with outcome after head injury. | Teasdale GM | Lancet (London, England) | 1997 | PMID: 10213549 |
Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease. | Kang AK | Mutation research | 1997 | PMID: 9360638 |
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. | Farrer LA | JAMA | 1997 | PMID: 9343467 |
Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia. | Richard P | Clinical science (London, England : 1979) | 1997 | PMID: 9279208 |
Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. | Tang MX | American journal of human genetics | 1996 | PMID: 8644717 |
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. | Myers RH | Neurology | 1996 | PMID: 8618665 |
Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. | Grace ME | The Journal of biological chemistry | 1994 | PMID: 8294487 |
Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. | van den Maagdenberg AM | American journal of human genetics | 1993 | PMID: 8488843 |
Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. | van den Maagdenberg AM | American journal of human genetics | 1993 | PMID: 8488843 |
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. | Saunders AM | Neurology | 1993 | PMID: 8350998 |
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. | Corder EH | Science (New York, N.Y.) | 1993 | PMID: 8346443 |
Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. | Tsuji S | Proceedings of the National Academy of Sciences of the United States of America | 1988 | PMID: 3353383 |
Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. | Das HK | The Journal of biological chemistry | 1985 | PMID: 3922972 |
Nucleotide sequence and structure of the human apolipoprotein E gene. | Paik YK | Proceedings of the National Academy of Sciences of the United States of America | 1985 | PMID: 2987927 |
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. | Weisgraber KH | The Journal of biological chemistry | 1981 | PMID: 7263700 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=APOE | - | - | - | - |
click to load more click to collapse |
Text-mined citations for this variant ...
HelpRecord last updated May 27, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.